FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1 (2023)
- Authors:
- USP affiliated authors: KOWALSKI, LUIZ PAULO - FM ; ROJAS, CÉSAR ALEXANDER ORTIZ - FMRP
- Unidades: FM; FMRP
- DOI: 10.1111/odi.14017
- Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS; QUIMIOTERÁPICOS; INIBIDORES DE ENZIMAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Oral diseases
- ISSN: 1354-523X
- Volume/Número/Paginação/Ano: v. 29, n. 2, p. 649-660, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ALMEIDA, Luciana Yamamoto de et al. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral diseases, v. 29, n. 2, p. 649-660, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52816. Acesso em: 12 fev. 2026. -
APA
Almeida, L. Y. de, Moreira, F. D. S., Santos, G. A. S. D., Zelaya, F. J. M. C., Ortiz Rojas, C. A., Agostini, M., et al. (2023). FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1. Oral diseases, 29( 2), 649-660. doi:10.1111/odi.14017 -
NLM
Almeida LY de, Moreira FDS, Santos GASD, Zelaya FJMC, Ortiz Rojas CA, Agostini M, Mariano FS, Bastos DC, Daher URN, Kowalski LP. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1 [Internet]. Oral diseases. 2023 ; 29( 2): 649-660.[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52816 -
Vancouver
Almeida LY de, Moreira FDS, Santos GASD, Zelaya FJMC, Ortiz Rojas CA, Agostini M, Mariano FS, Bastos DC, Daher URN, Kowalski LP. FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1 [Internet]. Oral diseases. 2023 ; 29( 2): 649-660.[citado 2026 fev. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52816 - Quantification of TP73 gene transcripts in acute promyelocytic leukemia and its impact on prognosis and treatment response
- SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
- Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review
- Depth of invasion applied to oropharynx does not improve prognosis discrimination according to AJCC stage groups for oral cancer. [Carta]
- Histological characteristics of early-stage oral tongue cancer in young versus older patients: a multicenter matched-pair analysis
- Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era
- Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus
- Robotic Head and Neck Surgery: Beyond TORS
- Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: a systematic review and meta-analysis
- Clinicopathological study and survival outcomes of sialoblastoma: A systematic review
Informações sobre o DOI: 10.1111/odi.14017 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003164562.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
